Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy

This publication has 11 references indexed in Scilit:

• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia
  Stroke, 2002
• Prevalence of Alzheimer’s disease in very elderly people
  Neurology, 2001
• Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression
  Archives of Neurology, 2001
• Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
  Neurotoxicity Research, 2000
• No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
  Life Sciences, 2000
• The incidence of dementia
  Neurology, 1998
• A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
  JAMA, 1994
• Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives
  Journal of Neurochemistry, 1993
• The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings
  International Journal of Epidemiology, 1991
• Excitotoxity and the NMDA receptor
  Trends in Neurosciences, 1987